GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
4 hedge funds and large institutions have $122K invested in VanEck Vectors Generic Drugs ETF in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
–
Holders Change %
0%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$4K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$683K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $64K | -$683K | -32,000 | -91% |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| $48K | – | – | – |
|
|
NFG
3
Next Financial Group
Houston,
Texas
| $6K | – | – | – |
|
|
LTFS
4
Ladenburg Thalmann Financial Services
Miami,
Florida
| $4K | +$4K | +200 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | -$6K | -240 | Closed |
|